XML 107 R90.htm IDEA: XBRL DOCUMENT v3.22.0.1
EQUITY-BASED COMPENSATION (Summary of Activity) (Details) - USD ($)
$ / shares in Units, $ in Thousands
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Stock options      
Options      
Stock options outstanding, beginning balance (in shares) 2,243,692    
Granted (in shares) 1,684,318    
Exercised (in shares) (165,268)    
Forfeited and canceled (in shares) 0    
Stock options outstanding, ending balance (in shares) 3,762,742 2,243,692  
Weighted-Average Exercise Price (per share)      
Stock options outstanding, beginning (in usd per share) $ 16.81    
Granted (in dollars per share) 26.35    
Stock options outstanding and exercisable (in usd per share) $ 21.02 $ 16.81  
Aggregate Intrinsic Value $ 29,951    
Weighted average remaining contractual term (in years) 8 years 3 months 18 days    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]      
Less: exercised/vested (in dollars per share) $ 18.22    
Restricted shares      
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding [Roll Forward]      
Beginning, Units outstanding (in shares) 578,802    
Granted (in shares) 662,423 545,806 113,121
Less: exercised / vested (in shares) 367,804    
Less: forfeited and canceled (in shares) (254,180)    
Ending, Units outstanding (in shares) 619,241 578,802  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]      
Beginning, weighted average exercise price (in dollars per share) $ 7.64    
Granted (in dollars per share) 8.48    
Less: exercised/vested (in dollars per share) 8.90    
Weighted average exercise / issuance price (per share) $ 8.02 $ 7.64  
Aggregate intrinsic value (in thousands) $ 5,569    
Weighted average remaining contractual term (in years) 1 year    
Common units      
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding [Roll Forward]      
Beginning, Units outstanding (in shares) 1,394,475    
Granted (in shares) 1,052,632 831,140 1,110,000
Less: exercised / vested (in shares) 1,223,265    
Less: forfeited and canceled (in shares) (263,013)    
Ending, Units outstanding (in shares) 960,829 1,394,475  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]      
Beginning, weighted average exercise price (in dollars per share) $ 1.14    
Granted (in dollars per share) 1.14    
Less: exercised/vested (in dollars per share) 1.13    
Weighted average exercise / issuance price (per share) $ 1.14 $ 1.14  
Aggregate intrinsic value (in thousands) $ 1,326    
Weighted average remaining contractual term (in years) 1 year 1 month 6 days